Evidence map›Paper›PMID 29764499›Full record

ArticleMicrobiome2018

Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum.

Mie Korslund Wiinblad Crusell, Tue Haldor Hansen, Trine Nielsen, Kristine Højgaard Allin, Malte C Rühlemann, Peter Damm, Henrik Vestergaard, Christina Rørbye, Niklas Rye Jørgensen, Ole Bjarne Christiansen and 5 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Microbiome, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07682077 (Effects of a Kefir Intervention in Pregnancy on Glucose, Insulin, Gestational Diabetes Mellitus, and the Gut Microbiome and Metabolites), which is not on this map. Cited by 280 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
280citing papers in PubMed, 11 pooled it
41.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07682077 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Effects of a Kefir Intervention in Pregnancy on Glucose, Insulin, Gestational Diabetes Mellitus, and the Gut Microbiome and Metabolites: A Randomized Controlled Trial

TypeinterventionalSponsorUniversity of New BrunswickRan2026 to 2029Enrolled60ConditionsGestational Diabetes Mellitus (GDM), Blood Glucose, Insulin Resistance, Diabetes, Gut MicrobiomeArmsKefir
3 · Its place in the literature

Who cites it

280 citing papers in PubMed, 11 syntheses or guidelines pooled it, 485 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Cellular and Molecular Pathophysiology of Gestational Diabetes.International journal of molecular sciences · 2024
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Maternal gut microbiota in the postpartum Period: A Systematic review.European journal of obstetrics, gynecology, and reproductive biology · 2023
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Imbalance of gut microbiota in gestational diabetes.BMC pregnancy and childbirth · 2024
    Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Article
  18. Review
  19. Review
  20. Obstetric Pharmacomicrobiomics.Clinical pharmacology and therapeutics · 2026
    Review

220 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Mie Korslund Wiinblad CrusellNovo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genetics, Faculty of Health and Medical Science, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen N, Denmark.
Tue Haldor HansenNovo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genetics, Faculty of Health and Medical Science, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen N, Denmark.
Trine NielsenNovo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genetics, Faculty of Health and Medical Science, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen N, Denmark.
Kristine Højgaard AllinNovo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genetics, Faculty of Health and Medical Science, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen N, Denmark.
Malte C RühlemannInstitute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, University Hospital Schleswig Holstein, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany.
Peter DammCenter for Pregnant Women with Diabetes, Department of Obstetrics, Rigshospitalet University Hospital, Blegdamsvej 9, 2100, Copenhagen Ø, Denmark.
Henrik VestergaardNovo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genetics, Faculty of Health and Medical Science, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen N, Denmark.
Christina RørbyeDepartment of Obstetrics and Gynaecology, Hvidovre University Hospital, Kettegaards Allé 30, 2650, Hvidovre, Denmark.
Niklas Rye JørgensenDepartment of Clinical Biochemistry, Rigshospitalet University Hospital, Blegdamsvej 9, 2100, Copenhagen Ø, Denmark.
Ole Bjarne ChristiansenDepartment of Obstetrics and Gynaecology, Rigshospitalet University Hospital, Blegdamsvej 9, 2100, Copenhagen Ø, Denmark.
Femke-Anouska HeinsenInstitute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, University Hospital Schleswig Holstein, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany.
Andre FrankeInstitute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, University Hospital Schleswig Holstein, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany.
Torben HansenNovo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genetics, Faculty of Health and Medical Science, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen N, Denmark.
Jeannet LauenborgDepartment of Obstetrics and Gynaecology, Herlev University Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark.
Oluf PedersenNovo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genetics, Faculty of Health and Medical Science, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen N, Denmark. oluf@sund.ku.dk.ORCID 0000-0002-3321-3972
University of Copenhagen · DKChristian-Albrechts-Universität zu Kiel · DEAalborg University Hospital · DKHerlev Hospital · DKHvidovre Hospital · DKUniversity of Southern Denmark · DK

Funding

Aase og Ejnar Danielsens Fond 10-001605Augustinus Fonden (DK) 1076001001
6 · The paper itself

Abstract

backgroundImbalances of gut microbiota composition are linked to a range of metabolic perturbations. In the present study, we examined the gut microbiota of women with gestational diabetes mellitus (GDM) and normoglycaemic pregnant women in late pregnancy and about 8 months postpartum.

methodsGut microbiota profiles of women with GDM (n = 50) and healthy (n = 157) pregnant women in the third trimester and 8 months postpartum were assessed by 16S rRNA gene amplicon sequencing of the V1-V2 region. Insulin and glucose homeostasis were evaluated by a 75 g 2-h oral glucose tolerance test during and after pregnancy.

resultsGut microbiota of women with GDM was aberrant at multiple levels, including phylum and genus levels, compared with normoglycaemic pregnant women. Actinobacteria at phylum level and Collinsella, Rothia and Desulfovibrio at genus level had a higher abundance in the GDM cohort. Difference in abundance of 17 species-level operational taxonomic units (OTUs) during pregnancy was associated with GDM. After adjustment for pre-pregnancy body mass index (BMI), 5 of the 17 OTUs showed differential abundance in the GDM cohort compared with the normoglycaemic pregnant women with enrichment of species annotated to Faecalibacterium and Anaerotruncus and depletion of species annotated to Clostridium (sensu stricto) and to Veillonella. OTUs assigned to Akkermansia were associated with lower insulin sensitivity while Christensenella OTUs were associated with higher fasting plasma glucose concentration. OTU richness and Shannon index decreased from late pregnancy to postpartum regardless of metabolic status. About 8 months after delivery, the microbiota of women with previous GDM was still characterised by an aberrant composition. Thirteen OTUs were differentially abundant in women with previous GDM compared with women with previous normoglycaemic pregnancy.

conclusionGDM diagnosed in the third trimester of pregnancy is associated with a disrupted gut microbiota composition compared with normoglycaemic pregnant women, and 8 months after pregnancy, differences in the gut microbiota signatures are still detectable. The gut microbiota composition of women with GDM, both during and after pregnancy, resembles the aberrant microbiota composition reported in non-pregnant individuals with type 2 diabetes and associated intermediary metabolic traits.

Indexed as

ActinobacteriaAdultBlood GlucoseBody Mass IndexClostridiumDesulfovibrioDiabetes, GestationalDysbiosisFaecalibacteriumFemaleGastrointestinal MicrobiomeGastrointestinal TractGlucoseHumansPostpartum PeriodPregnancyBlood GlucoseGlucoseRNA, Ribosomal, 16SBacterial speciesBody mass indexGestational diabetesGestational hyperglycaemiaGlycaemic traitsGut microbiotaPregnancy

Identifiers

PMID29764499
PMCPMC5952429
OpenAlexW2805293481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.